ライフサイエンスコーパス: oligoarticular

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 tory findings were similar for children with oligoarticular and polyarticular disease, differences in

2 onset PsJIA bear similarities to early-onset oligoarticular and polyarticular JIA patients, including

3 tibility in Finnish patients with persistent oligoarticular and polyarticular rheumatoid factor (RF)-

4 (JIA), comprising the most common subtypes (oligoarticular and rheumatoid factor-negative polyarticu

5 be an effective treatment for both extended oligoarticular and systemic JIA in this shortterm trial.

6 In the extended oligoarticular arthritis group, MTX treatment produced s

7 eumatology criteria for systemic or extended oligoarticular arthritis were eligible for this multicen

8 patients with systemic and 43 with extended oligoarticular arthritis were enrolled.

9 polyarticular, but not those with persistent oligoarticular, disease (P = 0.06, OR 2.9 [95% CI 0.9-9.

10 children, although joint involvement remains oligoarticular in the majority of children.

11 cantly lower in patients with extended-to-be oligoarticular JIA (0.57 compared with 0.90 in the persi

12 T cells, which was a significant feature of oligoarticular JIA (n = 62) as compared to polyarticular

13 rts [219 systemic JIA (sJIA), 187 persistent oligoarticular JIA (pOJIA), and 139 extended OJIA (eOJIA

14 o were employed (P = 0.03) and in those with oligoarticular JIA (t = 2.29, P = 0.02).

15 ples from patients with early- or late-onset oligoarticular JIA (with 97% accuracy) or from patients

16 o DRB1 and was similar between patients with oligoarticular JIA and a younger subgroup of patients wi

17 jor classifier of samples from patients with oligoarticular JIA and patients with polyarticular JIA.

18 HLA-DRB1*1103/1104, found in the group with oligoarticular JIA and the group of younger patients wit

19 ubtypes (P = 0.0097); children with extended oligoarticular JIA had the longest interval (median 60 w

20 ch to predict the likelihood of extension of oligoarticular JIA to a more severe disease phenotype.

21 tive systemic JIA and 9 with active extended oligoarticular JIA was assessed by real-time polymerase

22 Patients with recent-onset oligoarticular JIA were identified and grouped according

23 edication (5%), and patients with persistent oligoarticular JIA were the most likely (68%).

24 scovery rate 5%) in PBMCs from children with oligoarticular JIA whose disease began before age 6 year

25 n 101 patients with JIA (79% female; 24 with oligoarticular JIA, 40 with polyarticular JIA, 18 with s

26 ts with recent-onset JIA (39 with persistent oligoarticular JIA, 45 with rheumatoid factor-negative p

27 .5 (95% CI 1.9-6.5) in those with persistent oligoarticular JIA, and 4.1 (95% CI 2.5-6.7) in those wi

28 Among patients with persistent oligoarticular JIA, most of the disease course was chara

29 Also in contrast to findings for oligoarticular JIA, patients with polyarticular arthriti

30 al fluid samples obtained from children with oligoarticular JIA, polyarticular JIA, or systemic JIA w

31 3 and C12orf30 variants were associated with oligoarticular JIA, while the STAT4 variant was associat

32 matoid factor-negative polyarticular JIA and oligoarticular JIA.

33 Uveitis is most common in extended oligoarticular JIA.

34 ral blood (PB) T cells from 20 patients with oligoarticular- or polyarticular-onset JIA.

35 , sera and synovial fluid from children with oligoarticular, polyarticular, or systemic-onset JRA wer

36 Patients with oligoarticular PsA cannot be accurately assessed for act

37 compared to the known IFN-mediated extended oligoarticular subtype.

38 randomising centre and pattern of arthritis (oligoarticular vs polyarticular).

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。